Immune reaction to sandfly saliva varies between individuals living in endemic areas

October 12, 2017
The Phlebotomus papatasi sandfly. Credit: Stephen Ausmus, USDA, Flickr

The Phlebotomus papatasi sandfly is responsible for spreading Leishmania throughout the tropics and subtropics. How individuals in areas endemic for Leishmania infection react to sandfly saliva depends on their long-term exposure to the flies, researchers now report PLOS Neglected Tropical Diseases TK.

Leishmania is found in 90 countries, and more than a million infections occur worldwide each year. Previous work has shown that P. papatasi saliva helps Leishmania parasites infect someone, by interacting with the immune system. But studies have also suggested that repeated exposure to P. papatasi without Leishmania may confer some protection against the parasite, leading researchers to launch studies on immunizations modeled after P. papatasi saliva.

In the new work, Amel Meddeb-Garnaoui and Wafa Kammoun-Rebai, of the Institut Pasteur de Tunis, and colleagues studied the immune responses against P. papatasi salivary gland extract (SGE) of 790 people living in areas of Tunisia endemic for cutaneous leishmaniasis. Some areas were classified as old foci for the disease, while others were emerging foci. Each person was followed over the course of a year, before and after the typical season for Leishmania transmission. They were tested for leishmanial infection with a skin test and blood was collected for immune analyses.

The team found that less than 30% of people in all foci had anti-SGE proliferation, and that people more exposed to sandfly bites had higher anti-saliva IgG immune responses, higher IFN- γ levels, and their immune responses to the SGE were more likely to be Th2-type cellular responses. Anti-saliva IgG responses, they found, were a risk factor for the development of .

"Data presented in this study suggest that differences in sand fly exposure levels and in prevalence of infection are associated with different profiles against P. papatasi saliva," the researchers say. "These data can contribute to a better understanding of the mechanisms that govern resistance or susceptibility to by Leishmania parasites upon transmission by the P. papatasi sandflies."

Explore further: Sandfly spit vaccinates mice against leishmaniasis infection

More information: Kammoun-Rebai W, Bahi-Jaber N, Naouar I, Toumi A, Ben Salah A, Louzir H, et al. (2017) Human cellular and humoral immune responses to Phlebotomus papatasisalivary gland antigens in endemic areas differing in prevalence of Leishmania major infection. PLoS Negl Trop Dis 11(10): e0005905. doi.org/10.1371/journal.pntd.0005905

Related Stories

Sandfly spit vaccinates mice against leishmaniasis infection

November 3, 2016
A vaccine against cutaneous leishmaniasis, a skin infection caused by Leishmania parasites, may be spitting distance away—sand fly spit, that is. Saliva from a species of the fly responsible for transmitting leishmaniasis ...

Meeting a microbe in the morning or in the evening: Is it all the same?

September 8, 2017
Does the time of day matter when our body is infected by a parasite? According to new research from McGill University, it matters a great deal.

Scientists reveal structure of potential leishmaniasis vaccine

March 9, 2017
Leishmaniasis, caused by the bite of a sand fly carrying a Leishmania parasite, infects around a million people a year around the world. Now, making progress toward a vaccine against the parasitic disease, researchers reporting ...

The human parasite Leishmania is a probiotic for the fly that carries it

July 22, 2014
The Leishmania parasite, which causes the human disease leishmaniasis, acts as a probiotic in the insect that transmits it to humans, protecting them from bacterial disease. Findings published in the open access journal Parasites ...

New information on a major player in chronic visceral leishmaniasis

October 4, 2017
In an article in the latest issue of PLOS Pathogens, INRS professor Simona Stäger and her team show how the parasite Leishmania donovani uses a physiological response to low oxygen levels (hypoxia) to establish a chronic ...

Recommended for you

Novel therapies for multidrug-resistant bacteria

October 23, 2017
During this innovative study published in PLOS One, researchers found that novel classes of compounds, such as metal-complexes, can be used as alternatives to or to supplement traditional antibiotics, which have become ineffective ...

Key discoveries offer significant hope of reversing antibiotic resistance

October 23, 2017
Resistance to antibiotics is becoming increasingly prevalent and threatens to undermine healthcare systems across the globe. Antibiotics including penicillins, cephalosporins and carbapenems are known as β-lactams and are ...

Pneumonia vaccine under development provides 'most comprehensive coverage' to date, alleviates antimicrobial concerns

October 20, 2017
In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

Newly discovered viral marker could help predict flu severity in infected patients

October 20, 2017
Flu viruses contain defective genetic material that may activate the immune system in infected patients, and new research published in PLOS Pathogens suggests that lower levels of these molecules could increase flu severity.

Migraines may be the brain's way of dealing with oxidative stress

October 19, 2017
A new perspective article highlights a compelling theory about migraine attacks: that they are an integrated mechanism by which the brain protects and repairs itself. Recent insightful findings and potential ways to use them ...

H7N9 influenza is both lethal and transmissible in animal model for flu

October 19, 2017
In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.